Cagrilintide-Semaglutide Improved HbA1c More Than Semaglutide in T2DM Tags hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Cagrilintide-Semaglutide Improved HbA1c More Than Semaglutide in T2DM
Finerenone Reduced Albuminuria Across HbA1c Levels in Type 1 Diabetes and CKD Tags Albuminuria Diabetic Nephropathy hBA1c Read more about Finerenone Reduced Albuminuria Across HbA1c Levels in Type 1 Diabetes and CKD
ADA 2026: Oral Ribupatide Achieved Up to 11.9% Weight Loss at 26 Weeks Tags GLP-1 agonists Read more about ADA 2026: Oral Ribupatide Achieved Up to 11.9% Weight Loss at 26 Weeks
Genetically Predicted GIP Modified T2DM Risk in Fatty Pancreas Disease Read more about Genetically Predicted GIP Modified T2DM Risk in Fatty Pancreas Disease
Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA Tags Coronary artery disease DPP-4 inhibitors Rheumatoid Arthritis (RA) SGLT-2 Inhibitor Read more about Cardiovascular Outcomes Were Similar Between SGLT2 and DPP-4 Inhibitors in RA
Osteoporosis Patients Receiving IV Bisphosphonates Showed Lower T2DM Risk Read more about Osteoporosis Patients Receiving IV Bisphosphonates Showed Lower T2DM Risk
TyG-WHtR Showed Stronger PAD Association Than TyG-BMI in T2DM Tags Peripheral vascular disease Read more about TyG-WHtR Showed Stronger PAD Association Than TyG-BMI in T2DM
Patients With DM and OH Demonstrated Higher Central BP and PWV Tags ASCVD Diabetic Neuropathy Myocardial infarction Read more about Patients With DM and OH Demonstrated Higher Central BP and PWV
GLP-1RA Therapy Was Not Associated With OA Risk in T2DM Tags GLP-1 agonists Read more about GLP-1RA Therapy Was Not Associated With OA Risk in T2DM
Low HALP Scores Were Linked to Higher Fracture Risk in T2DM Read more about Low HALP Scores Were Linked to Higher Fracture Risk in T2DM